An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
This study is being undertaken to: 1. assess the safety of fluorouracil cream for the
treatment of actinic keratoses ("AKs") on other common skin surface areas (e.g., posterior
scalp, ears, neck, lips, arms and hands); 2. collect additional post-treatment safety data on
fluorouracil cream applied to the face (including anterior scalp, if applicable); 3. assess
the incidence of recurrence of AKs on the face; and 4. assess the need for re-treatment with
fluorouracil cream to the face.